Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer.
Flores LF, Marks DL, Vera RE, Sigafoos AN, Tolosa EJ, Almada LL, Pease DR, Toruner MD, Chang B, Tader BR, LaRue-Nolan KC, Carr RM, Graham RP, Hagen CE, Brown MR, Matveyenko AV, Wilson KL, Dawson DW, Pin CL, Roux KJ, Fernandez-Zapico ME.
Flores LF, et al. Among authors: matveyenko av.
JCI Insight. 2025 Jun 10:e187799. doi: 10.1172/jci.insight.187799. Online ahead of print.
JCI Insight. 2025.
PMID: 40493403
Free article.